COULTREON BIOPHARMA
La probabilité de faillite calculée de COULTREON BIOPHARMA sur 12 mois est de 1,1% (faible). L'entreprise est active depuis 2025 et le Moniteur belge ne contient aucun signal d'insolvabilité ou d'avertissement. Aucun chiffre de comptes annuels traité n'est disponible ; cette conclusion repose uniquement sur les données du registre et du Moniteur belge.
| Active | 1 ans |
| Direction | 3 |
| Sites | 1 |
| Publications | 7 |
Estimation statistique fondée sur des sources publiques, pas un conseil de crédit ni une constatation. Comment calculons-nous cela ?
-
Actif20-11-2025 → auj.
-
Vuldex Consulting BVPersonne moraleAdministrateur· repr. perm.: Marie De VulderActe Moniteur 25151961 (01-12-2025)Actif01-06-2025 → auj.
-
Pierre Raboisson BVPersonne moraleAdministrateur délégué· repr. perm.: Pierre RaboissonActe Moniteur 25151961 (01-12-2025)Actif01-04-2025 → auj.
2 événements
- 01-06-2025 Nommé· Administrateur délégué
- 01-04-2025 Nommé· Administrateur
| NACE primaire | Fabrication de médicaments(21201) |
| Forme juridique | SRL(610) |
| Date de constitution | 30-01-2025 |
| Status | Actif |
| Code postal | 3001 |
Afficher 2 autres connexions réseau
Parcelles liées à cette entreprise via ses adresses BCE (siège, unités d'établissement, succursales), croisées avec le plan parcellaire cadastral. Ceci montre où l'entreprise est active, pas un registre de propriété.
| Parcelle (capakey) | Région | Superficie | Bâtiments | Hauteur / ét. |
|---|---|---|---|---|
| 24040B0218/00V002 | Flandre | 2 297 m² | 1 · 1 484 m² | 2,6 m |
Une seule chronologie de tout ce qui est arrivé à cette entreprise, publications, événements d'insolvabilité et de cycle de vie, changements administratifs et comptes annuels déposés.
Nous connaissons 6 actes du Moniteur belge pour cette entreprise. Aucun n'a encore été lu : ce qui s'y trouve n'a ici été ni constaté ni réfuté.
04-08-2026 Act object · Notarial deed · Incorporation · Founder
- Act object: OPRICHTING · Stichting Administratiekantoor Coultreon
- Publication: 04/08/2026 · Stichting Administratiekantoor Coultreon
- Filing: 31-07-2026 · Stichting Administratiekantoor Coultreon
- Notarial deed: 31-07-2026 · Stichting Administratiekantoor Coultreon
- Incorporation: 31-07-2026 · Stichting Administratiekantoor Coultreon
- Founder · COULTREON BIOPHARMA
- Purpose: De private stichting wordt opgericht ter verwezenlijking van het volgend belangeloos doel: het bevorderen van een stabiel aandeelhouderschap van Coultreon Biopharma, met het oog op een efficiënte en eenvoudige besluitvorming binnen Coultreon Biopharma (waarvan de Aandelen worden gecertificeerd overeenkomstig de voorwaarden zoals bepaald in de Administratievoorwaarden en de Aandeelhoudersovereenkomt). De private stichting beoogt met deze structuur een duurzame scheiding tot stand te brengen tussen de economische gerechtigheid tot de Aandelen en de uitoefening van de daaraan verbonden zeggenschapsrechten. De private stichting zal fungeren als administratiekantoor van de Aandelen van Coultreon Biopharma. · Stichting Administratiekantoor Coultreon
- First fiscal year: 31-12-2027 · Stichting Administratiekantoor Coultreon
- Officer appointment: role: bestuurder, term: onbepaalde duur, start_date: 2026-07-31 · Pierre Raboisson BV
- Permanent representative · Pierre RABOISSON
- Officer appointment: role: bestuurder, term: onbepaalde duur, start_date: 2026-07-31 · Vuldex Consulting BV
- Permanent representative · Marie DE VULDER
- Officer appointment: role: bestuurder, term: onbepaalde duur, start_date: 2026-07-31 · SKJ Consult BV
- Permanent representative · Guy PEETERS
- Mandate compensation: onbezoldigd · Pierre Raboisson BV
- Mandate compensation: onbezoldigd · Vuldex Consulting BV
- Mandate compensation: onbezoldigd · SKJ Consult BV
- Filing representative: vervulling van de formaliteiten bij het rechtspersonenregister alsook bij een ondernemingsloket met het oog op de inschrijving van de gegevens van de private stichting in de Kruispuntbank van Ondernemingen · Osborne Clarke BV
- Filing representative: het verkrijgen van de rechtspersoonlijkheid van de vereniging en de publicatie van de statuten in de Bijlagen bij het Belgisch Staatsblad · Berquin Notarissen
Détails techniques
{
"facts": [
{
"type": "act_object",
"quote": "Onderwerp akte : OPRICHTING",
"value": "OPRICHTING",
"object": null,
"subject": "e1"
},
{
"date": "2026-08-04",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 04/08/2026",
"value": "04/08/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-31",
"type": "filing",
"quote": "Neergelegd 31-07-2026",
"value": "31-07-2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-31",
"type": "notarial_deed",
"quote": "Het jaar tweeduizend zesentwintig. Op eenendertig juli. (...) Voor mij, Tim CARNEWAL, notaris te Brussel",
"value": "31-07-2026",
"object": "e10",
"subject": "e1"
},
{
"date": "2026-07-31",
"type": "incorporation",
"quote": "Het jaar tweeduizend zesentwintig. Op eenendertig juli. (...) IS VERSCHENEN: de besloten vennootschap \u0022COULTREON BIOPHARMA\u0022 (...) Die mij notaris, gevraagd heeft bij authentieke akte de oprichting en de statuten vast te stellen van de hierna genoemde private stichting",
"value": "31-07-2026",
"object": null,
"subject": "e1"
},
{
"type": "founder",
"quote": "De stichter van de private stichting is Coultreon Biopharma, voornoemd.",
"value": null,
"object": "e1",
"subject": "e2"
},
{
"type": "purpose",
"quote": "Artikel 7. Doel \u2013 Voorwerp 7.1. ... 7.2. ...",
"value": "De private stichting wordt opgericht ter verwezenlijking van het volgend belangeloos doel: het bevorderen van een stabiel aandeelhouderschap van Coultreon Biopharma, met het oog op een effici\u00EBnte en eenvoudige besluitvorming binnen Coultreon Biopharma (waarvan de Aandelen worden gecertificeerd overeenkomstig de voorwaarden zoals bepaald in de Administratievoorwaarden en de Aandeelhoudersovereenkomt). De private stichting beoogt met deze structuur een duurzame scheiding tot stand te brengen tussen de economische gerechtigheid tot de Aandelen en de uitoefening van de daaraan verbonden zeggenschapsrechten. De private stichting zal fungeren als administratiekantoor van de Aandelen van Coultreon Biopharma.",
"object": null,
"subject": "e1"
},
{
"date": "2027-12-31",
"type": "first_fiscal_year",
"quote": "Het eerste boekjaar is een verlengd boekjaar dat aanvangt op de dag dat de private stichting rechtspersoonlijkheid verwerft en eindigt op 31 december 2027.",
"value": "31-12-2027",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-31",
"type": "officer_appointment",
"quote": "De stichter benoemt als bestuurders voor onbepaalde duur: - Pierre Raboisson BV",
"value": {
"role": "bestuurder",
"term": "onbepaalde duur",
"start_date": "2026-07-31"
},
"object": "e1",
"subject": "e3",
"_value_raw": {
"role": "bestuurder",
"term": "onbepaalde duur",
"start_date": "31-07-2026"
}
},
{
"type": "permanent_representative",
"quote": "Pierre Raboisson BV ... (met als vaste vertegenwoordiger de heer Pierre RABOISSON",
"value": null,
"object": "e3",
"subject": "e4"
},
{
"date": "2026-07-31",
"type": "officer_appointment",
"quote": "De stichter benoemt als bestuurders voor onbepaalde duur: ... - Vuldex Consulting BV",
"value": {
"role": "bestuurder",
"term": "onbepaalde duur",
"start_date": "2026-07-31"
},
"object": "e1",
"subject": "e5",
"_value_raw": {
"role": "bestuurder",
"term": "onbepaalde duur",
"start_date": "31-07-2026"
}
},
{
"type": "permanent_representative",
"quote": "Vuldex Consulting BV ... (met als vaste vertegenwoordiger Marie DE VULDER",
"value": null,
"object": "e5",
"subject": "e6"
},
{
"date": "2026-07-31",
"type": "officer_appointment",
"quote": "De stichter benoemt als bestuurders voor onbepaalde duur: ... - SKJ Consult BV",
"value": {
"role": "bestuurder",
"term": "onbepaalde duur",
"start_date": "2026-07-31"
},
"object": "e1",
"subject": "e7",
"_value_raw": {
"role": "bestuurder",
"term": "onbepaalde duur",
"start_date": "31-07-2026"
}
},
{
"type": "permanent_representative",
"quote": "SKJ Consult BV ... (met als vaste vertegenwoordiger Guy PEETERS",
"value": null,
"object": "e7",
"subject": "e8"
},
{
"type": "mandate_compensation",
"quote": "Hun opdracht wordt niet vergoed.",
"value": "onbezoldigd",
"object": "e1",
"subject": "e3"
},
{
"type": "mandate_compensation",
"quote": "Hun opdracht wordt niet vergoed.",
"value": "onbezoldigd",
"object": "e1",
"subject": "e5"
},
{
"type": "mandate_compensation",
"quote": "Hun opdracht wordt niet vergoed.",
"value": "onbezoldigd",
"object": "e1",
"subject": "e7"
},
{
"type": "filing_representative",
"quote": "De oprichters verlenen bijzondere volmacht aan David HAEX, Tonya AELBRECHT, Violette KEPPENNE, Karen CALVO VLEUGELS en Ga\u00EBtan CNOPS, advocaten bij Osborne Clarke BV ... teneinde de vervulling van de formaliteiten bij het rechtspersonenregister alsook bij een ondernemingsloket met het oog op de inschrijving van de gegevens van de private stichting in de Kruispuntbank van Ondernemingen, te verzekeren.",
"value": "vervulling van de formaliteiten bij het rechtspersonenregister alsook bij een ondernemingsloket met het oog op de inschrijving van de gegevens van de private stichting in de Kruispuntbank van Ondernemingen",
"object": "e1",
"subject": "e9"
},
{
"type": "filing_representative",
"quote": "De stichters geven volmacht aan \u00E9\u00E9n van de notarissen van \u201CBerquin Notarissen\u201D, teneinde de noodzakelijke stappen te ondernemen met het oog op het verkrijgen van de rechtspersoonlijkheid van de vereniging en de publicatie van de statuten in de Bijlagen bij het Belgisch Staatsblad.",
"value": "het verkrijgen van de rechtspersoonlijkheid van de vereniging en de publicatie van de statuten in de Bijlagen bij het Belgisch Staatsblad",
"object": "e1",
"subject": "e10"
}
],
"act_meta": {
"outcome": "corrected",
"postfix": [
"primary company kbo missing -\u003E register 1040.853.946"
],
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 35775,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "1040.853.946",
"kind": "company",
"name": "Stichting Administratiekantoor Coultreon",
"attrs": {
"seat": "Gaston Geenslaan 3, 3001 Heverlee",
"kbo_source": "register",
"legal_form": "Private stichting",
"short_name": "STAK Coultreon"
}
},
{
"id": "e2",
"kbo": "1019.429.814",
"kind": "company",
"name": "COULTREON BIOPHARMA",
"attrs": {
"seat": "Gaston Geenslaan 3, 3001 Leuven (Heverlee)",
"short_name": "COULTREON"
}
},
{
"id": "e3",
"kbo": "1021.701.592",
"kind": "company",
"name": "Pierre Raboisson BV",
"attrs": {
"seat": "Avenue Denis Diderot 5, 1300 Wavre, Belgi\u00EB"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Pierre RABOISSON",
"attrs": {
"birth_date": "1970-09-22",
"birth_place": "Mulhouse (Frankrijk)"
}
},
{
"id": "e5",
"kbo": "1015.286.033",
"kind": "company",
"name": "Vuldex Consulting BV",
"attrs": {
"seat": "Parklaan 50, 9140 Temse, Belgi\u00EB"
}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Marie DE VULDER",
"attrs": {
"birth_date": "1985-09-30",
"birth_place": "Aalst"
}
},
{
"id": "e7",
"kbo": "1022.653.974",
"kind": "company",
"name": "SKJ Consult BV",
"attrs": {
"seat": "De Zwaantjes 4, 2390 Malle, Belgi\u00EB"
}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Guy PEETERS",
"attrs": {
"birth_date": "1977-10-14",
"birth_place": "Turnhout"
}
},
{
"id": "e9",
"kbo": null,
"kind": "org",
"name": "Osborne Clarke BV",
"attrs": {
"seat": "Marsveldplein 5, 1050 Elsene"
}
},
{
"id": "e10",
"kbo": null,
"kind": "org",
"name": "Berquin Notarissen",
"attrs": {
"seat": "Lloyd Georgelaan 11, Brussel"
}
}
]
}05-05-2026 Changement au sein de l'organe d'administration
Détails techniques
{
"events": [
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Pierre Raboisson",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "PIERRE RABOISSON BV",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "2"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Lawrence M Blatt",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": null,
"statutory": null,
"compensated": true,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "2"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Maha Katabi",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "2"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Max Klement",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "2"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Rogier Rooswinkel",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "2"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Guy Peeters",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "SKJ CONSULT BV",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Peter VERHAEGHE",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "SKJ CONSULT BV",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Emmanuel CASIER",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "SKJ CONSULT BV",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marie De Vulder",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "VULDEX CONSULTING BV",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Matthieu DERYNCK",
"firm_city": null,
"firm_name": "Van Halteren Notarissen",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2026-05-05",
"filing_date": "2026-04-30",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2026-04-22",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "1019.429.814",
"name_full": "COULTREON BIOPHARMA",
"legal_form": "BV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Matthieu DERYNCK",
"org_rep_person_name": null,
"person_role_at_subject": "notaris"
},
"co_filed_documents": [
"expeditie",
"verslagen",
"volmachten",
"bankattesten"
],
"corrected_publication_numac": null
}20-04-2026 Publication au Moniteur belge, Modification mineure
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"detected_kind": "other",
"effective_date": null,
"mandate_renewal": null,
"subject_company": {
"kbo": "1019.429.814",
"name_full": "ONCO3R THERAPEUTICS",
"legal_form": "BV"
},
"liquidation_closure": null,
"officer_designation": null,
"special_procuration": null,
"single_shareholder_declaration": null
}02-03-2026 2 administrateurs nommés, 1 démissionnaire
- Lawrence Blatt, Bestuurder
- SKJ Consult BV, Bestuurder
- Vuldex Consulting BV, Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Vuldex Consulting BV",
"address": null,
"birth_date": null
},
"effective_date": "2025-12-12",
"evidence_quote": "De vergadering nam kennis van het ontslag van Vuldex Consulting BV, met ondernemingsnummer 1015.283.033 en zetel te Parklaan 50, 9140 Temse, vast vertegenwoordigd door Marie De Vulder wonende te Parklaan 50, 9140 Temse, als bestuurder met ingang van 12 December 2025.",
"discharge_granted": true
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Lawrence Blatt",
"address": null,
"birth_date": null
},
"effective_date": "2025-11-20",
"evidence_quote": "De vergadering besloot met eenparigheid van stemmen om Lawrence Blatt, met Amerikaanse nationaliteit en met adres voor doeleinden van dit mandaat kiezende en dit conform artikel 28 van de statuten te Gaston Geenslaan 3, 3001 Leuven, te benoemen als bestuurder van de vennootschap met ingang van 20 no"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "SKJ Consult BV",
"address": null,
"birth_date": null
},
"effective_date": "2025-12-12",
"evidence_quote": "De vergadering besloot met eenparigheid van stemmen om aan SKJ Consult BV, met ondernemingsnummer 1022.653.974 en zetel te De Zwaantjes 4, 2390 Malle, vast vertegenwoordigd door Guy Peeters, wonende te De Zwaantjes 4, 2390 Malle te benoemen als bestuurder/CFO van de Vennootschap met ingang van 12 De"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1019.429.814",
"name_full": "ONCO3R THERAPEUTICS",
"legal_form": "BV"
}
}01-12-2025 2 administrateurs nommés
- Pierre Raboisson, Gedelegeerd bestuurder
- Marie De Vulder, Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Pierre Raboisson",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Pierre Raboisson BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-06-01",
"evidence_quote": "De vergadering besliste met eenparigheid van stemmen om Pierre Raboisson BV met zetel te Avenue Denis Diderot 5, 1300 Wavre, vast vertegenwoordigd door Pierre Raboisson wonende te Avenue Denis Diderot 5, 1300 Wavre, te benoemen als gedelegeerd bestuurder / CEO van de Vennootschap met ingang vanaf 1 "
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marie De Vulder",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Vuldex Consulting BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-06-01",
"evidence_quote": "De vergadering besliste met eenparigheid van stemmen om Vuldex Consulting BV met zetel te Parklaan 50, 9140 Temse, vast vertegenwoordigd door Marie De Vulder wonende te Parklaan 50, 9140 Temse, te benoemen als bestuurder en als Chief Legal Officer van de Vennootschap met ingang vanaf 1 juni 2025 en "
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1019.429.814",
"name_full": "ONCO3R THERAPEUTICS",
"legal_form": "BV"
}
}17-06-2025 Pierre Raboisson nommé administrateur
- Pierre Raboisson, Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Pierre Raboisson",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "PIERRE RABOISSON BV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-04-01",
"evidence_quote": "De vergadering besliste met eenparigheid van stemmen om PIERRE RABOISSON BV te benoemen als bestuurder van Onco3R Therapeutics BV met ingang vanaf 1 april 2025. De vergadering nam kennis dat de heer Pierre Raboisson werd aangeduid om als vast vertegenwoordiger te ageren van PIERRE RABOISSON BV bij h"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1019.429.814",
"name_full": "ONCO3R THERAPEUTICS",
"legal_form": "BV"
}
}03-02-2025 Constitution d'une société (BV)
Détails techniques
{
"kind": "oprichting",
"seat": "Barricadenplein 13, 1000 Brussel",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Pierre Raboisson",
"niss": null,
"address": "Avenue Denis Diderot 5, 1300 Waver"
},
"share_class": "Aandelen op naam",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 17000,
"holder_person_name": "Pierre Raboisson",
"is_subscriber_only": false,
"n_shares_subscribed": 170,
"amount_subscribed_eur": 17000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Pieter Peeters",
"niss": null,
"address": "Dijkstraat 42, 2480 Dessel"
},
"share_class": "Aandelen op naam",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 15000,
"holder_person_name": "Pieter Peeters",
"is_subscriber_only": false,
"n_shares_subscribed": 150,
"amount_subscribed_eur": 15000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Francois Gonzalvez",
"niss": null,
"address": "Raketlaan 14, 1150 Sint-Pieters-Woluwe"
},
"share_class": "Aandelen op naam",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 15000,
"holder_person_name": "Francois Gonzalvez",
"is_subscriber_only": false,
"n_shares_subscribed": 150,
"amount_subscribed_eur": 15000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Marie De Vulder",
"niss": null,
"address": "Parklaan 50, 9140 Temse"
},
"share_class": "Aandelen op naam",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 15000,
"holder_person_name": "Marie De Vulder",
"is_subscriber_only": false,
"n_shares_subscribed": 150,
"amount_subscribed_eur": 15000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Joost Kolkman",
"niss": null,
"address": "Berkenlaan 7, 3951XW Maarn, Nederland"
},
"share_class": "Aandelen op naam",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 8000,
"holder_person_name": "Joost Kolkman",
"is_subscriber_only": false,
"n_shares_subscribed": 80,
"amount_subscribed_eur": 8000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Sandrine Vendeville",
"niss": null,
"address": "Bemelstraat 142, 1150 Sint-Pieters-Woluwe"
},
"share_class": "Aandelen op naam",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 8000,
"holder_person_name": "Sandrine Vendeville",
"is_subscriber_only": false,
"n_shares_subscribed": 80,
"amount_subscribed_eur": 8000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 78000,
"subject_company": {
"kbo": "1019.429.814",
"name_full": "ONCO3R Therapeutics",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2025-01-24",
"post_incorporation_mandates": []
}| Dénomination légaleNL | COULTREON BIOPHARMA |
| Dénomination légaleNL | ONCO3R Therapeutics |
| AbréviationNL | COULTREON |